Hindustan Times: Mumbai: Friday, July 14, 2017.
An increasing
number of patients are dropping out of treatment for tuberculosis (TB) in the
city, according to data collated by a city-based non-government organisation
(NGO).
A report
released by Praja Foundation on Wednesday revealed an 11% increase in TB
patients who have dropped out of treatment from the city’s public hospitals and
clinics over five years (2012 - 2016).
According to
the report, there were 2,638 patients who dropped out of treatment in 2012,
which rose to 2,927 in 2016.
The therapy
known as directly observed treatment, short-course (DOTS) (see box) is provided
by the government under the Revised National Tuberculosis Control Programme
(RNTCP).
Under DOTS,
the intake of medicines by patients is monitored to ensure that they adhere to
the prescribed dosage and schedule.
Moreover, the
number of TB cases registered at government institutions has also increased by
a substantial 37%, claims Praja.
“TB treatment
usually lasts between six months to a year. The issue is whether the government
is doing enough to follow up on all the cases registered for treatment under
DOTS?” said Nitai Mehta, from Praja Foundation.
The NGO
attained the data through queries made under the Right to Information (RTI)
Act.
However, Dr
Daksha Shah, the city’s TB officer, said the data has been misinterpreted by
Praja as some of the defaulters calculated for each year could have registered
in the previous year.
The NGO
should have asked for total number of patients under treatment in a particular
year, she added.
“Most of the
defaulters are patients from villages who go out of the city during their
treatment. When they go back to the village without informing the programme
officer, it gets very tough to reach them,” she said.
She added
that a lot of patients under treatment are alcoholics, who refuse to
takemedicines despite repeated counselling.
Doctors said
there are dire public health consequences when tuberculosis patients abruptly
abandon treatment as they could acquire drug resistance and as a result, infect
other people too.
“As these
people move freely in the community they infect people with a bacilli strain
which is already drug resistant. This is called primary infection and is a
major concern now,” said Dr Alpa Dalal, head of department, pulmonary medicine,
Thane.